OPTIOptec International Inc

$0.0003
$0.00
(0.00%)
Today
Updated: 01:36 PM EDT
Mkt Cap$1.42M
Vol2.54M
News
all
press releases
News Placeholder
Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update
This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN), a commercial-stage psychedelic pharmaceutical manufacturer, welcomed final recommendations from Australia’s Therapeutic Goods Administration regarding its Authorized Prescriber scheme for psilocybin and MDMA. The updated framework broadens eligible therapy teams, expands treatment settings beyond […]
Investor Brand Network
<
...
1
>

Advertisement|Remove ads.